BRD4 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(3) The bromodomain inhibitor IBET-151 attenuates vismodegib-resistant esophageal adenocarcinoma growth through reduction of GLI signalingOncotargetAugust 18, 2020Alvarez-Trotta A, Wang Z, Shersher E, Li B, Long J, Lohse I, Wahlestedt C, El-Rifai W, Robbins DJ, Capobianco AJ.

(4) BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cellsCancer lettersJune 1, 2020Camero S, Camicia L, Marampon F, Ceccarelli S, Shukla R, Mannarino O, Pizer B, Schiavetti A, Pizzuti A, Tombolini V, et al.

(8) MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathwayCancer medicineApril 1, 2019Guan H, You Z, Wang C, Fang F, Peng R, Mao L, Xu B, Chen M.

(10) Recruitment of Brd3 and Brd4 to acetylated chromatin is essential for proinflammatory cytokine-induced matrix-degrading enzyme expressionJournal of orthopaedic surgery and researchFebruary 20, 2019Dai J, Zhou S, Ge Q, Qin J, Li J, Ju H, Cao Y, Zheng M, Li C, Gao X, et al.

(11) Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expressionJournal of experimental & clinical cancer research : CRFebruary 6, 2019Shi W, Zhang C, Ning Z, Hua Y, Li Y, Chen L, Liu L, Chen Z, Meng Z.

(12) BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic SyndromesFrontiers in oncologyJanuary 1, 2019Pericole FV, Lazarini M, de Paiva LB, Duarte ADSS, Vieira Ferro KP, Niemann FS, Roversi FM, Olalla Saad ST.

(13) Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in VivoCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacologyJanuary 1, 2019Qin AC, Li Y, Zhou LN, Xing CG, Lu XS.

(14) Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate CancerMolecular cancer therapeuticsDecember 1, 2018Nerlakanti N, Yao J, Nguyen DT, Patel AK, Eroshkin AM, Lawrence HR, Ayaz M, Kuenzi BM, Agarwal N, Chen Y, et al.

(15) microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4Biochemical and biophysical research communicationsJuly 2, 2018He L, Meng D, Zhang SH, Zhang Y, Deng Z, Kong LB.

(16) Bromodomain-Containing Protein 4 (BRD4) Inhibition Sensitizes Palomid 529-Induced Anti-Renal Cell Carcinoma Cell Activity in Vitro and in VivoCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacologyJanuary 1, 2018Xing ZY, Wang Y, Cheng L, Chen J, He XZ, Xing W.

(17) BRD4 inhibitor JQ1 inhibits and reverses mechanical injury-induced corneal scarringCell death discoveryJanuary 1, 2018Qu M, Zhang X, Hu X, Dong M, Pan X, Bian J, Zhou Q.

(18) Transcription Elongation Factor P-TEFb Is Involved in IL-17F Signaling in Airway Smooth Muscle CellsInternational archives of allergy and immunologyJanuary 1, 2018Nakajima M, Kawaguchi M, Matsuyama M, Ota K, Fujita J, Matsukura S, Huang SK, Morishima Y, Ishii Y, Satoh H, et al.

(20) Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expressionOncotargetJanuary 19, 2016Li GQ, Guo WZ, Zhang Y, Seng JJ, Zhang HP, Ma XX, Zhang G, Li J, Yan B, Tang HW, et al.

BRD4 shRNA Plasmid (h)